Matthews GV - Search Results

1

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy.

Cunningham EB, Hajarizadeh B, Amin J, Litwin AH, Gane E, Cooper C, Lacombe K, Hellard M, Read P, Powis J, Dalgard O, Bruneau J, Matthews GV, Feld JJ, Dillon JF, Shaw D, Bruggmann P, Conway B, Fraser C, Marks P, Dore GJ, Grebely J; SIMPLIFY and D3FEAT study groups. Cunningham EB, et al. Among authors: matthews gv. Clin Infect Dis. 2020 Oct 23;71(7):e115-e124. doi: 10.1093/cid/ciz1089. Clin Infect Dis. 2020. PMID: 31677262 Free article.

2

Response to Soriano et al., 'Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?'.

Matthews G, Dore G. Matthews G, et al. AIDS. 2003 Dec 5;17(18):2675-6. doi: 10.1097/01.aids.0000104338.15729.9a. AIDS. 2003. PMID: 14685063 No abstract available.

3

Treatment for hepatitis C virus infection among current injection drug users in Australia.

Matthews G, Kronborg IJ, Dore GJ. Matthews G, et al. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S325-9. doi: 10.1086/427448. Clin Infect Dis. 2005. PMID: 15768342 Review.

4

Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.

Matthews GV, Dore GJ. Matthews GV, et al. AIDS. 2007 Mar 30;21(6):777-8. doi: 10.1097/QAD.0b013e3280b07774. AIDS. 2007. PMID: 17413705 No abstract available.

5

Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.

Matthews GV, Cooper DA, Dore GJ. Matthews GV, et al. Antivir Ther. 2007;12(1):119-22. Antivir Ther. 2007. PMID: 17503756

6

Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.

Revill PA, Littlejohn M, Ayres A, Yuen L, Colledge D, Bartholomeusz A, Sasaduesz J, Lewin SR, Dore GJ, Matthews GV, Thio CL, Locarnini SA. Revill PA, et al. Among authors: matthews gv. AIDS. 2007 Aug 20;21(13):1701-10. doi: 10.1097/QAD.0b013e32826fb305. AIDS. 2007. PMID: 17690567

7

Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al.

Matthews GV, Hellard M, Kaldor J, Lloyd A, Dore GJ. Matthews GV, et al. AIDS. 2007 Oct 1;21(15):2112-3. doi: 10.1097/QAD.0b013e3282ef3873. AIDS. 2007. PMID: 17885306 No abstract available.

8

The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure.

Matthews GV, Grebely J, Dore GJ. Matthews GV, et al. J Hepatol. 2008 Sep;49(3):305-7. doi: 10.1016/j.jhep.2008.06.005. Epub 2008 Jun 26. J Hepatol. 2008. PMID: 18644647 Free article. No abstract available.

9

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.

Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, Petcharapirat P, Marks P, Sasadeusz J, Cooper DA, Bowden S, Locarnini S, Ruxrungtham K, Dore GJ. Matthews GV, et al. Hepatology. 2008 Oct;48(4):1062-9. doi: 10.1002/hep.22462. Hepatology. 2008. PMID: 18697216 Clinical Trial.

10

HIV and hepatitis C coinfection.

Matthews GV, Dore GJ. Matthews GV, et al. J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1000-8. doi: 10.1111/j.1440-1746.2008.05489.x. J Gastroenterol Hepatol. 2008. PMID: 18707597 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

248 results

Search Page